Christopher Callesano, Chief Financial Officer of Moelis & Co (NYSE:MC), filed a Form 4 on September 21, 2026, disclosing the acquisition of dividend equivalent Restricted Stock Units across four separate incentive RSU grants, all with a transaction date of September 17, 2026.
Katherine Pilcher Ciafone, Chief Operating Officer of Moelis & Co (NYSE:MC), filed a Form 4 on September 21, 2026, reporting the acquisition of dividend equivalent Restricted Stock Units on September 17, 2026.
Nick Riehl, Principal Accounting Officer of Moelis & Co (NYSE:MC), filed a Form 4 on September 21, 2026, reporting the acquisition of five tranches of dividend equivalent Restricted Stock Units across multiple RSU grant programs, with all transactions dated September 17, 2026.
Director Laila Worrell filed a Form 4 with the U.S. Securities and Exchange Commission on September 21, 2026, disclosing the acquisition of restricted stock units in Moelis & Co (NYSE:MC) on September 17, 2026, through dividend equivalent grants across three RSU categories.
Eric Cantor, Vice Chairman and Managing Director at Moelis & Company (NYSE:MC), filed a Form 4 on September 21, 2026, reporting the acquisition of dividend equivalent Restricted Stock Units across five RSU grant series, all dated September 17, 2026.
Director Kenneth Shropshire filed a Form 4 with the SEC on September 21, 2026, reporting the acquisition of dividend equivalent Restricted Stock Units in Moelis & Co (NYSE:MC) on September 17, 2026.
Director Louise Mirrer filed a Form 4 with the SEC on September 21, 2026, reporting the acquisition of restricted stock units issued as dividend equivalents on her existing annual RSU holdings in Moelis & Co (NYSE:MC).
Thorold Barker, a director of Moelis & Co (NYSE:MC), filed a Form 4 on September 21, 2026, reporting the acquisition of restricted stock units issued as dividend equivalents on two separate tranches of annual RSUs.
A statement of changes in beneficial ownership filed on September 21, 2026, disclosed that William P. Scully, a director of Prothena Corp Public Ltd Co (NASDAQ:PRTA), purchased 100,000 ordinary shares on September 18, 2026.
A Form 4 filed with the SEC on September 21, 2026, discloses that Andy Dignan, President of Five9, Inc. (NASDAQ:FIVN), sold 6,986 shares of common stock on September 17, 2026, under a pre-established Rule 10b5-1 trading plan.